China Business Information Network News: Pharmaceutical intermediates are a kind of fine chemical products in the production process from pharmaceutical chemical raw materials to APIs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical product can be produced in ordinary chemical plants without a drug production license. As long as it reaches some levels, it can be used for drug synthesis.
In recent years, the pharmaceutical intermediate industry in China has been highly valued by governments at all levels and supported by national industrial policies. The state has successively introduced a number of policies to encourage the development and innovation of the pharmaceutical intermediate industry. Industrial policies such as the Measures for the Supervision and Administration of Pharmaceutical Production (revised in 2020), the Measures for the Administration of Pharmaceutical Injections (revised in 2020), and the Announcement on the Issuance of the Work Plan for the Reform of the Registration and Classification of Chemical Drugs have provided a clear and broad market prospect for the development of the pharmaceutical intermediate industry and a good production and operation environment for enterprises.
Source: Prepared by China Commercial Industry Research Institute
Previous：What is the export prospect of pharmaceutical intermediates?
Next：Analysis of the upstream, middle and downstream markets of China's biomedical industry chain in 2022